Omega (AIM: ODX), the medical diagnostics company focused on CD4, infectious diseases and food intolerance, notes today’s update from Abingdon Health plc (AIM: ABDX)
Omega Diagnostics Gp (ODX.L) Update re AbC-19 Rapid Test
Omega Diagnostics Group PLC (ODX.L) Mologic CE Mark Rapid Antigen Test
Omega (AIM: ODX), the medical diagnostics company focused on CD4, infectious diseases and food intolerance, welcomes the news that Mologic Ltd (“Mologic”) has received CE Mark for it’s professional-use COVID-19
Omega Diagnostics Gp (ODX.L) UK-RTC Update
Omega (AIM: ODX), the medical diagnostics company focused on CD4, infectious diseases and food intolerance, notes the press release issued today by the UK Rapid Test Consortium (“UK-RTC”), of which
Omega Diagnostics Gp (ODX.L) Chinese approval for Food Detective® test
Omega (AIM: ODX), the medical diagnostics company focused on CD4, infectious diseases and food intolerance, announces that the National Medical Products Administration (“NMPA”), formerly the China Food and Drug Administration,
Midatech Pharma PLC (MTPH.L) Headline Results of MTX110 Phase I DIPG Study
Phase II Dose Confirmed and Encouraging Survival Data
TPI provides its latest research note on Midatech Pharma plc (MTPH.L).
Midatech has today announced encouraging headline results from a Phase I study at the University of California, San Francisco (‘UCSF’) in patients with the orphan condition, Diffuse Intrinsic Pontine Glioma
TPI provides its latest research note on Midatech Pharma plc (MTPH.L)
Midatech has announced unaudited interim results for the six months ended 30 June 2020. These cover a period of significant transition for the Group, subsequent to which it has raised
Sareum Holdings PLC (SAR.L) Research Update
Encouraging Preclinical Results Generated with Sareum’s TYK2/JAK1 Inhibitors in a Disease Model of Lupus
Evgen Pharma PLC (EVG.L) SFX-01 to be evaluated in COVID-19 trial
Evgen Pharma plc (AIM: EVG), the clinical stage drug development company, is delighted to announce participation in the recently notified funding initiative for COVID-19 clinical trials by the medical research
Evgen Pharma (EVG.L) Clinical trial that could reduce Covid-19 deaths
The University of Dundee is leading the clinical trial of a new anti-inflammatory drug it is hoped may reduce instances of severe lung damage and death in Covid-19 patients.
TPI provides its latest research note on Midatech Pharma plc (MTPH.L).
Midatech has announced it has entered into a research collaboration with Dr Reddy’s Laboratories (BSE:500124, NSE:DRREDDY, NYSE:RDY) (‘Dr. Reddy’s), the global pharmaceutical company.
